Looking for value in the stock market is something that I have found can be done in any market condition, but it is something that tends to get dismissed by most pundits simply because it isn’t very sexy. Names like Tesla, Netflix, and Amazon practically never pass the value list because the massive amount of […]
Read MoreESSA Pharma Inc. (EPIX) SSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. ESSA Pharma Inc. has a collaboration […]
Read More(Bloomberg) — Johnson & Johnson shares jumped after the maker of cancer treatments, mouthwash and Tylenol said it will break itself up into two public companies, one focused on drugs and medical devices, and the other on consumer products. The health-care giant will split off its consumer division in 18 to 24 months, the company […]
Read MoreOver the course of my investing career, I have learned to rely on a lot of fundamental data to paint a picture about the underlying strength of any stock I might consider using for a value-based investment. While some fundamental investors prefer to work with easy-to-reference, quick-glance data like earnings per share and price-to-earnings ratios, […]
Read MoreFor most of the past two years, stocks in the Health Care sector have drawn a lot of attention from investors and analysts. That includes stocks in the Pharmacy/Drugstore industry; these were names, like Walgreens Boots Alliance (WBA) and CVS Corporation (CVS) that worked actively in the early stages of the crisis as a critical […]
Read MoreOrganogenesis Holdings Inc., a regenerative medicine company, develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company’s advanced wound care products include Affinity, an amniotic allograft wound covering and surgical barrier for application in the care of chronic and acute wounds or surgical […]
Read MoreThese 2 stocks lagged in July, but trader say last month’s weakness is this month’s buying opportunity. This is why you may want to consider these stocks now.
Read MoreThere is a lot of fundamental data that I rely on to help paint an overall picture about underlying strength of any stock I might consider using for a value-based investment. While some fundamental investors prefer to work with easy-to-reference, quick-glance data like earnings per share, I prefer to expand my view of a company’s […]
Read MoreIn market terms, one of the natural side effects of the COVID-19 health crisis has been an elevated focus on stocks in the Healthcare sector. That covers a wide range of industries, from health insurance to biopharmaceutical and healthcare equipment and supplies. All of these companies have spent the last year and a half not […]
Read MoreBuy Price: $42.00 or better Sell Price: TradersPro Sell Signal Select Medical Holdings Corporation, through its subsidiary, Select Medical Corporation, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. The company’s Critical Illness Recovery Hospital segment consists of hospitals that provide services for heart failure, infectious […]
Read MoreIn market terms, one of the natural side effects of the COVID-19 health crisis has been an elevated focus on stocks in the Healthcare sector. That covers a wide range of industries, from health insurance to biopharmaceutical and healthcare equipment and supplies. All of these companies have spent the last eighteen months not only coping […]
Read MoreWhen economists and market analysts look back at the last year and talk about the most impactful trends that emerged as a result of the COVID-19 pandemic, the conversation inevitably steers towards remote work. Corporations around the world were forced to adjust their operational models in rapid fashion, sending large numbers of their workers to […]
Read MorePlus, the U.S. is buying 100 million additional doses of Johnson & Johnson’s COVID-19 vaccine, Apple is reportedly cutting its iPhone production by 20% due to lower than expected demand for its iPhone 12 mini model, and SunRun shares are up on two analyst upgrades.
Read MoreThere is a lot of fundamental data that I rely on to help paint an overall picture about underlying strength of any stock I might consider using for a value-based investment. While some fundamental investors prefer to work with easy-to-reference, quick-glance data like earnings per share, I prefer to expand my view of a company’s […]
Read MoreFor most of the past year, any examination of the Pharmaceutical industry begins and ends with COVID-19 vaccines. Literally, of course, this isn’t true; diseases of all kinds don’t take a holiday during a pandemic, and so development of existing projects for any company in this industry hasn’t stopped, either. Nonetheless, the massive, immediate impact […]
Read More